Xiaojing Yang

940 total citations
43 papers, 739 citations indexed

About

Xiaojing Yang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaojing Yang has authored 43 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Xiaojing Yang's work include Glycosylation and Glycoproteins Research (10 papers), Galectins and Cancer Biology (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Xiaojing Yang is often cited by papers focused on Glycosylation and Glycoproteins Research (10 papers), Galectins and Cancer Biology (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Xiaojing Yang collaborates with scholars based in Canada, China and United States. Xiaojing Yang's co-authors include Inka Brockhausen, Y Hao, Ning Liu, L Raptis, Zhijiang Zhou, Ming‐Sound Tsao, Tassos Anastassiades, Frederick W. K. Kan, Danping Wang and Mark Harrison and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Xiaojing Yang

41 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojing Yang Canada 15 379 155 129 103 82 43 739
Simonetta Petrungaro Italy 16 468 1.2× 138 0.9× 94 0.7× 92 0.9× 206 2.5× 27 827
Elizabeth R. Smith United States 17 528 1.4× 102 0.7× 150 1.2× 79 0.8× 54 0.7× 27 819
Yunbae Pak South Korea 21 545 1.4× 330 2.1× 167 1.3× 44 0.4× 50 0.6× 49 1.0k
Taisuke Nakayama Japan 17 382 1.0× 92 0.6× 56 0.4× 54 0.5× 62 0.8× 55 828
Yusuke Nakamura Japan 13 414 1.1× 48 0.3× 179 1.4× 48 0.5× 66 0.8× 38 734
Tomoko Inoue Japan 19 565 1.5× 83 0.5× 286 2.2× 175 1.7× 91 1.1× 50 1.0k
Jae‐Hoon Ji South Korea 16 569 1.5× 122 0.8× 190 1.5× 136 1.3× 96 1.2× 31 898
Yan‐Jiun Huang Taiwan 17 354 0.9× 155 1.0× 226 1.8× 80 0.8× 68 0.8× 48 901
Yanlin Ma China 19 769 2.0× 46 0.3× 134 1.0× 85 0.8× 57 0.7× 66 1.1k
Jennifer S. Searle United States 7 537 1.4× 103 0.7× 112 0.9× 96 0.9× 85 1.0× 8 765

Countries citing papers authored by Xiaojing Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Yang more than expected).

Fields of papers citing papers by Xiaojing Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Yang. The network helps show where Xiaojing Yang may publish in the future.

Co-authorship network of co-authors of Xiaojing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Yang. A scholar is included among the top collaborators of Xiaojing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Yang. Xiaojing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ning, Luyao Wang, Kun Sun, et al.. (2021). Silica nanoparticle induces pulmonary fibroblast transdifferentiation via macrophage route: Potential mechanism revealed by proteomic analysis. Toxicology in Vitro. 76. 105220–105220. 19 indexed citations
2.
Yang, Xiaojing, Sadegh Saghafinia, Xiantao Wang, et al.. (2021). A miR-375/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells. Scientific Reports. 11(1). 10455–10455. 13 indexed citations
3.
Yang, Xiaojing, Ruonan Wang, Li Wang, et al.. (2021). β-hydroxybutyrate Alleviates Learning and Memory Impairment Through the SIRT1 Pathway in D-Galactose-Injured Mice. Frontiers in Pharmacology. 12. 20 indexed citations
4.
Jiang, Yuchen, Libin Yang, Xiaojing Yang, et al.. (2020). The imidazopyridine derivative X22 prevents diabetic kidney dysfunction through inactivating NF-κB signaling. Biochemical and Biophysical Research Communications. 525(4). 877–882. 2 indexed citations
5.
Ginter, Paula S., Kathrin Tyryshkin, Xiaojing Yang, et al.. (2020). Classifying Lung Neuroendocrine Neoplasms through MicroRNA Sequence Data Mining. Cancers. 12(9). 2653–2653. 12 indexed citations
6.
Wang, Rui, Li Wang, Jinlong He, et al.. (2019). Specific Inhibition of CYP4A Alleviates Myocardial Oxidative Stress and Apoptosis Induced by Advanced Glycation End-Products. Frontiers in Pharmacology. 10. 876–876. 10 indexed citations
7.
Yang, Xiaojing, et al.. (2016). Recombinant human oviductin regulates protein tyrosine phosphorylation and acrosome reaction. Reproduction. 152(5). 561–573. 25 indexed citations
8.
Anastassiades, Tassos, et al.. (2013). N-acylated glucosamines for bone and joint disorders: effects of N-butyryl glucosamine on ovariectomized rat bone. Translational research. 162(2). 93–101. 7 indexed citations
9.
Guo, Zijian, et al.. (2013). Association of 8q24 rs13281615A > G polymorphism with breast cancer risk: evidence from 40,762 cases and 50,380 controls. Molecular Biology Reports. 40(6). 4065–4073. 4 indexed citations
10.
11.
Zhou, Zhijiang, Y Hao, Ning Liu, et al.. (2011). TAZ is a novel oncogene in non-small cell lung cancer. Oncogene. 30(18). 2181–2186. 144 indexed citations
12.
Xiong, Sheng, Jun Fan, Feng Ge, et al.. (2010). In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action. British Journal of Pharmacology. 159(4). 909–918. 17 indexed citations
13.
Brockhausen, Inka, et al.. (2008). Acceptor substrate specificity of UDP-Gal: GlcNAc-R β1,3-galactosyltransferase (WbbD) from Escherichia coli O7:K1. Glycoconjugate Journal. 25(7). 663–673. 11 indexed citations
14.
Li, Yi, et al.. (2007). Requirement of N-glycosylation for the secretion of recombinant extracellular domain of human Fas in HeLa cells. The International Journal of Biochemistry & Cell Biology. 39(9). 1625–1636. 22 indexed citations
15.
Yang, Xiaojing, et al.. (2007). Primary human osteoblasts and bone cancer cells as models to study glycodynamics in bone. The International Journal of Biochemistry & Cell Biology. 40(3). 471–483. 12 indexed citations
16.
Brockhausen, Inka, Xiaojing Yang, & Mark Harrison. (2006). Analysis of the Glycodynamics of Primary Osteoblasts and Bone Cancer Cells. Humana Press eBooks. 347. 211–236. 4 indexed citations
17.
Yang, Xiaojing, et al.. (2006). The action of TNFα and TGFβ include specific alterations of the glycosylation of bovine and human chondrocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(2). 264–272. 18 indexed citations
18.
Yang, Xiaojing, et al.. (2004). The effect of TNF-α on glycosylation pathways in bovine synoviocytes. Biochemistry and Cell Biology. 82(5). 559–568. 34 indexed citations
19.
Yang, Xiaojing, et al.. (2003). Soluble human core 2 β6-N-acetylglucosaminyltransferase C2GnT1 requires its conserved cysteine residues for full activity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1648(1-2). 62–74. 14 indexed citations
20.
Brockhausen, Inka, Fabienne Vavasseur, & Xiaojing Yang. (2001). Biosynthesis of mucin type O-glycans: Lack of correlation between glycosyltransferase and sulfotransferase activities and CFTR expression. Glycoconjugate Journal. 18(9). 685–697. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026